|Day Low/High||121.65 / 123.38|
|52 Wk Low/High||118.62 / 148.32|
These 'recession-resistant' names have proven they can thrive in a variety of economic conditions and through changing technologies and sentiments.
Johnson & Johnson is among the companies that Jim Cramer has put on his new GLOOM index.
Jim Cramer says we need stocks that are in sync with the global gloom and can be bought when we feel gloomy, which is pretty much every day.
Here is a new index for all you traders out there to follow, compliments of TheStreet's founder Jim Cramer. Welcome to the GLUM Index.
Looking for stocks with a steady stream of income? Check these three names out from TheStreet.
Taking the measure of what's keeping the markets in the dumps.
Next generation LASIK platform that measures the eye inside and out to enable highly precise personalized vision correction
The latest announcement from the U.S. Trade Representative's office is chilling reading for free trade supporters.
BOSTON, June 14, 2018 /PRNewswire/ -- Kyros Law Offices is alerting individuals that have suffered serious side effects from taking Invokana that it is investigating filing legal claims seeking compensation for their injuries.
Eli Lilly, AstraZeneca and vTv Therapeutics show why it's best to stay away from biotech's black hole.
Jim Cramer's new rules of the road will help investors stay on course and avoid common mistakes.
While a handful of drug companies say their average net prices have dropped, FDA Commissioner Scott Gottlieb announces a plan to encourage drug competition in the face of monopolies.
Tech and retail gains aren't enough to lead markets to new highs.
JNJ is one of the best of breed of the pharmaceuticals sector.
Annual Health for Humanity Report Discloses Progress on Global Commitments and Highlights Key Achievements Toward Eradicating and Preventing Disease, Reimagining Care Delivery and Promoting Lifelong Health
Johnson & Johnson Launches New Programs to Fuel Diverse Champions of Science
Jim Cramer says the market like this economy; he has your game plan for next week.
Johnson & Johnson is a premiere company, but the trick is knowing when to buy it.
Combining the lower-risk fund with a higher-risk one could make sense.
The market is sliding. Let's look at the top stocks that are trading at 52 week highs and 52 week lows.
Jim Cramer says it's extremely important to buy stocks that are exactly right for you and your level of risk tolerance.
Simon Greenstone Panatier represents 66-year-old woman with deadly cancer
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.